MEDREICH LTD WALK IN ON 05/11/16 @ BANGLORE

REFERENCE

Srinivasulu Tirumalasetty

Global pharma News

Walk-in Interviews - Medreich- R&D- Bangalore (05-11-2016) Saturday.

Positions vacant in (AR&D – FR&D)- Analytical development and Formulation Development.

Walk in Details:- (Only Experienced candidates 1 to 6 years)

Date- 05-11-2016

Time- 9 to 1.00 PM.

Venue : Medreich Limited (R&D-Genovo)
Plot No. 36, Bommasandra Industrial Area,
Anekal Taluk, Bommasandra,
Bangalore-560099

Land Mark - Karnataka Bank, Jigani Road

Contact Person : Mr. Amogh

Contact No : 080-41658083/84

Can mail us- sekhar.s@medreich.com / Amogh.n@medreich.com

Officer / Executive Formulation Development

Development of Solids (Tablets: IR, DR & ER dosage forms & Capsules: Powder and Pellets filled).
Should independently carry out the Formulation R&D and scale up activities. 

Experience in handling equipments like RMG, Fluid bed driers & Granulators, size reduction mills, Blenders, compression, coating & capsule filling machines.

Preparation and review of Stability, Scale up, Process validation protocols and reports, Specifications (Raw material, Packaging material & product) etc.

(EU, US & Emerging Markets) and requirements, Good Documentation Practices.

Qualification : M Pharma ( Pharmaceutics) / PhD.

Officer / Executive – Analytical Development

Candidate should have experience in Method development, Method validation of different pharmaceutical dosage forms.

Hands on experience/ knowledge in handling Analytical work related to DS and DPs in different phases with a proven track record (having worked with Global partners/ International exposure).
Hands on experience in Chromatography (HPLC, UPLC, HSGC), Spectroscopy (FTIR, UV), dissolution apparatus and Particle size measurements. Well versed with 21CFR Part 11 and other global laboratory compliances requirements.

Qualification : M Pharma ( Analysis), MSC Chemistry.

For more updates follow srinivasulutirumalasetty.blogspot.com

Thank you for visiting my blog , Visit again for latest pharma updates